Emyria and Mind Medicine Australia to launch Psychedelic-Assisted Therapy Program (EMDMA-001) for PTSD
Mind Medicine Australia, May 10, 2021
On Wednesday 5 May, Emyria (ASX:EMD) and Mind Medicine Australia announced their first psychedelic-assisted therapy care program (EMDMA-001) for sufferers of treatment resistant post-traumatic stress disorder (PTSD).
It’s time to give our military the medicine they need
Spectator | Australia, May 6, 2021
Sadly, many of the more than 39,000 soldiers who served in Afghanistan will have varying degrees of post-traumatic stress disorder (PTSD). Innovative treatments are urgently needed to treat PTSD. With mounting pressure, the TGA recently announced an Independent Review on rescheduling both psylocibin and MDMA.
100 Most Influential People in Psychedelics
Psyched Studio, May 5, 2021
Mind Medicine Australia’s co-Founder, Tania de Jong AM has been shortlisted in the 100 Most Influential People in Psychedelics by Psyched Studio.
100 Most Influential People in Psychedelics
Psychedelic Invest, May 3, 2021
Psychedelic Invest has compiled a list of the top 100 most influential people in the psychedelics ecosystem, including our Co-Founder Tania de Jong AM.
Psychedelics for Mental Health
Metagenics Institute Podcast, April 27, 2021
In this episode, Nathan sits down with Tania de Jong and Dr Alana Roy from Mind Medicine Australia to discuss the use of psychedelics for mental health.
‘Illicit drugs’ and mental health treatment: all we are asking for is hope
Canberra Times, April 22, 2021
“I am writing this as a mother, in the hope that my words may open the closed minds of our politicians and the authorities we rely upon to ensure every Australian has access to the latest medical therapies.” – Annie Mason
The Weekly With Charlie Pickering
The Weekly With Charlie Pickering, April 21, 2021
Feature on psychedelics in Australia, Mind Medicine Australia and the TGA.
MDMA and magic mushrooms reconsidered for rescheduling by Therapeutic Goods Administration
Canberra Times, April 18, 2021
An application to make MDMA and psilocybin more easily accessible to psychiatrists for mental health treatments will now be independently reviewed following an earlier rejection.
It’s about patient choice says Tasmanian doctor who believes magic mushrooms and MDMA can help treat depression and PTSD
The Advocate, March 25, 2021
A Tasmanian doctor says the state’s mental health crisis would be greatly assisted by MDMA and psilocybin assisted therapies, especially for emergency responders impacted by trauma and those with treatment-resistant illness.
Psychedelic therapy: Air force veteran’s wild journey back from the abyss
News.com.au, March 18, 2021
After 16-and-a-half years in the air force, Michael Raymond had seen it all. But by repressing his feelings, he began to push himself down a dark path. His mental health began to deteriorate even further and he was placed on suicide watch. Ultimately, Michael was healed through psychedelic-assisted therapy.
Government commits $15m for psychedelic drug therapy trials
ABC PM with Linda Mottram, March 18, 2021
The federal government has committed $15 million for the development of psychedelic drug therapies for mental illness. In clinical trials around the world, MDMA, magic mushrooms and ketamine are showing promising results in treating PTSD and depression. Advocacy groups have welcomed the trials but want the prohibited drugs reclassified so they can be used more readily for psycho-therapy.
The Admiral and the Ecstasy
ABC Conversations, March 18, 2021
Chris Barrie is convinced that the Australian Government should legalise the clinical use of specific psychedelics to help veterans recovering from trauma.
Australian government backs psychedelic drug clinical trials to treat mental illness
The Guardian, March 18, 2021
$15m grant comes despite TGA’s failure to reschedule MDMA and psilocybin from a prohibited substance to a controlled medicine
Former trade minister Andrew Robb supports psychedelic medicines
9 News, March 17, 2021
The use of psilocybin, MDMA and other psychedelic medicines to treat mental illness will soon undergo clinical trials funded by the federal government. It’s backed by former Trade Minister Andrew Robb but not all psychiatrists are convinced.
‘Better treatments’: Government to fund psychedelic drugs trials to treat mental illness
Sydney Morning Herald, March 17, 2021
Clinical trials using psilocybin, MDMA and other psychedelic medicines in potential breakthrough therapies for debilitating mental illnesses will be funded by the federal government as part of global efforts to advance innovative treatments.
Australian War Memorial expansion better invested in psychedelic-assisted therapy research
Canberra Times, March 14, 2021
ACT pill testing advocate David Caldicott has voiced disgust over the $500 million expansion of the Australian War Memorial he said the federal government had “inflicted” on the city, while emerging treatments for post traumatic stress disorder were deemed too hard.
When pills stopped working, Andrew Robb looked to magic mushroom therapy
ABC News, March 11, 2021
When his daily pile of antidepressant pills stopped working, former Liberal Party director and trade minister Andrew Robb began researching psychedelic therapy as an option to send his depression into remission.
Andrew Robb interviewed by James Valentine, ABC Radio Sydney
Afternoons, March 11, 2021
The interview commences at 1 hour and 2 minutes.
Report with Leigh Sales interviewing Andrew Robb AO, Dr Stuart Saker and more
ABC 7.30, March 11, 2021
Leigh Sales interviewing Andrew Robb AO, psychiatrist Dr Stuart Saker and patient on psychedelic-assisted therapies to treat mental illness. The segment commences at 21:45
Suicide warning over denied drugs
The Australian, March 9, 2021
Delaying mental practitioners access to psilocybin and MDMA could result in a spike in suicides amid an ongoing national mental health crisis, according to advocates for psychedelic-assisted therapy.